The U.S. District Court for the District of Hawaiʻi entered judgment in favor of the Hawaiʻi Department of Health and the Director of Health in a lawsuit challenging the Department’s regulations prohibiting the sale of Delta-8 and Delta-10 THC products processed from hemp.
In February 2022, the Department of Health promulgated interim rules prohibiting the sale or distribution of hemp with Delta-8 or Delta-10 THC, in addition to hemp containing Delta-9 THC concentrations exceeding 0.3 percent.
The plaintiff Duke’s Investments LLC, which operated as “Pinky’s Hempire,” alleged that the Department of Health’s interim administrative rules regarding hemp processing were illegal and that the prohibition on Delta-8 and Delta-10 THC products was unconstitutional.
ARTICLE CONTINUES BELOW AD
ARTICLE CONTINUES BELOW AD
The U.S. District Court sided with the Department of Health and the Director of Health, represented by Hawaiʻi deputy attorneys General Isaac Ickes and Skyler Cruz, and dismissed the case.
“We appreciate the Court’s well-reasoned analysis of the issues in this case,” said Ickes.
This comments section is a public community forum for the purpose of free expression. Although Big Island Now encourages respectful communication only, some content may be considered offensive. Please view at your own discretion. View Comments
